Logo image of ALRIB.PA

RIBER SA (ALRIB.PA) Stock Fundamental Analysis

Europe - EPA:ALRIB - FR0000075954 - Common Stock

3.21 EUR
-0.07 (-2.13%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ALRIB. ALRIB was compared to 59 industry peers in the Semiconductors & Semiconductor Equipment industry. ALRIB has an average financial health and profitability rating. ALRIB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ALRIB had positive earnings in the past year.
ALRIB had a positive operating cash flow in the past year.
ALRIB had positive earnings in each of the past 5 years.
Of the past 5 years ALRIB 4 years had a positive operating cash flow.
ALRIB.PA Yearly Net Income VS EBIT VS OCF VS FCFALRIB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

ALRIB has a Return On Assets (6.75%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 14.77%, ALRIB is in line with its industry, outperforming 55.38% of the companies in the same industry.
ALRIB's Return On Invested Capital of 12.44% is fine compared to the rest of the industry. ALRIB outperforms 64.62% of its industry peers.
Industry RankSector Rank
ROA 6.75%
ROE 14.77%
ROIC 12.44%
ROA(3y)5.23%
ROA(5y)3.98%
ROE(3y)11.42%
ROE(5y)8.61%
ROIC(3y)N/A
ROIC(5y)N/A
ALRIB.PA Yearly ROA, ROE, ROICALRIB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Profit Margin of ALRIB (8.26%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ALRIB has grown nicely.
ALRIB's Operating Margin of 9.86% is on the low side compared to the rest of the industry. ALRIB is outperformed by 66.15% of its industry peers.
In the last couple of years the Operating Margin of ALRIB has grown nicely.
Looking at the Gross Margin, with a value of 36.56%, ALRIB is doing worse than 76.92% of the companies in the same industry.
ALRIB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.86%
PM (TTM) 8.26%
GM 36.56%
OM growth 3Y33.22%
OM growth 5Y31.15%
PM growth 3Y28.64%
PM growth 5Y25.02%
GM growth 3Y0.64%
GM growth 5Y4.07%
ALRIB.PA Yearly Profit, Operating, Gross MarginsALRIB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALRIB is still creating some value.
ALRIB has about the same amout of shares outstanding than it did 1 year ago.
ALRIB has less shares outstanding than it did 5 years ago.
ALRIB has a better debt/assets ratio than last year.
ALRIB.PA Yearly Shares OutstandingALRIB.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ALRIB.PA Yearly Total Debt VS Total AssetsALRIB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

ALRIB has an Altman-Z score of 3.10. This indicates that ALRIB is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 3.10, ALRIB is not doing good in the industry: 67.69% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.02 indicates that ALRIB is not too dependend on debt financing.
ALRIB has a better Debt to Equity ratio (0.02) than 89.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 3.1
ROIC/WACC1.19
WACC10.49%
ALRIB.PA Yearly LT Debt VS Equity VS FCFALRIB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

ALRIB has a Current Ratio of 1.43. This is a normal value and indicates that ALRIB is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALRIB (1.43) is worse than 81.54% of its industry peers.
ALRIB has a Quick Ratio of 1.43. This is a bad value and indicates that ALRIB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.51, ALRIB is doing worse than 92.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.51
ALRIB.PA Yearly Current Assets VS Current LiabilitesALRIB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

The earnings per share for ALRIB have decreased strongly by -30.91% in the last year.
Measured over the past years, ALRIB shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.74% on average per year.
The Revenue has decreased by -6.64% in the past year.
ALRIB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.20% yearly.
EPS 1Y (TTM)-30.91%
EPS 3Y41.89%
EPS 5Y30.74%
EPS Q2Q%-594.94%
Revenue 1Y (TTM)-6.64%
Revenue growth 3Y9.68%
Revenue growth 5Y4.2%
Sales Q2Q%-22.1%

3.2 Future

ALRIB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.78% yearly.
ALRIB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.95% yearly.
EPS Next Y0%
EPS Next 2Y17.51%
EPS Next 3Y20.78%
EPS Next 5YN/A
Revenue Next Year-1.2%
Revenue Next 2Y7.64%
Revenue Next 3Y9.95%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALRIB.PA Yearly Revenue VS EstimatesALRIB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALRIB.PA Yearly EPS VS EstimatesALRIB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.40, which indicates a rather expensive current valuation of ALRIB.
Based on the Price/Earnings ratio, ALRIB is valued a bit cheaper than the industry average as 72.31% of the companies are valued more expensively.
ALRIB is valuated rather cheaply when we compare the Price/Earnings ratio to 27.42, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 10.75, the valuation of ALRIB can be described as reasonable.
ALRIB's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALRIB is cheaper than 93.85% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, ALRIB is valued rather cheaply.
Industry RankSector Rank
PE 21.4
Fwd PE 10.75
ALRIB.PA Price Earnings VS Forward Price EarningsALRIB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

72.31% of the companies in the same industry are more expensive than ALRIB, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.3
ALRIB.PA Per share dataALRIB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ALRIB's earnings are expected to grow with 20.78% in the coming years.
PEG (NY)N/A
PEG (5Y)0.7
EPS Next 2Y17.51%
EPS Next 3Y20.78%

6

5. Dividend

5.1 Amount

ALRIB has a Yearly Dividend Yield of 2.44%.
ALRIB's Dividend Yield is rather good when compared to the industry average which is at 1.10. ALRIB pays more dividend than 95.38% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, ALRIB has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.44%

5.2 History

On average, the dividend of ALRIB grows each year by 7.02%, which is quite nice.
Dividend Growth(5Y)7.02%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

ALRIB pays out 53.27% of its income as dividend. This is a bit on the high side, but may be sustainable.
ALRIB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP53.27%
EPS Next 2Y17.51%
EPS Next 3Y20.78%
ALRIB.PA Yearly Income VS Free CF VS DividendALRIB.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M
ALRIB.PA Dividend Payout.ALRIB.PA Dividend Payout, showing the Payout Ratio.ALRIB.PA Dividend Payout.PayoutRetained Earnings

RIBER SA

EPA:ALRIB (10/17/2025, 7:00:00 PM)

3.21

-0.07 (-2.13%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)09-25 2025-09-25
Earnings (Next)01-27 2026-01-27/amc
Inst Owners0.53%
Inst Owner ChangeN/A
Ins Owners23.64%
Ins Owner ChangeN/A
Market Cap68.21M
Analysts84.44
Price Target3.98 (23.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.44%
Yearly Dividend0.07
Dividend Growth(5Y)7.02%
DP53.27%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 21.4
Fwd PE 10.75
P/S 1.79
P/FCF N/A
P/OCF 32.7
P/B 3.2
P/tB 4.16
EV/EBITDA 12.3
EPS(TTM)0.15
EY4.67%
EPS(NY)0.3
Fwd EY9.31%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.1
OCFY3.06%
SpS1.79
BVpS1
TBVpS0.77
PEG (NY)N/A
PEG (5Y)0.7
Profitability
Industry RankSector Rank
ROA 6.75%
ROE 14.77%
ROCE 16.92%
ROIC 12.44%
ROICexc 12.44%
ROICexgc 15.99%
OM 9.86%
PM (TTM) 8.26%
GM 36.56%
FCFM N/A
ROA(3y)5.23%
ROA(5y)3.98%
ROE(3y)11.42%
ROE(5y)8.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y42.85%
ROICexcg growth 5Y7.69%
ROICexc growth 3Y39.73%
ROICexc growth 5Y10.6%
OM growth 3Y33.22%
OM growth 5Y31.15%
PM growth 3Y28.64%
PM growth 5Y25.02%
GM growth 3Y0.64%
GM growth 5Y4.07%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA 0.08
Cap/Depr 134.21%
Cap/Sales 7.07%
Interest Coverage 235
Cash Conversion 36.17%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 0.51
Altman-Z 3.1
F-Score4
WACC10.49%
ROIC/WACC1.19
Cap/Depr(3y)112.18%
Cap/Depr(5y)116.77%
Cap/Sales(3y)6.89%
Cap/Sales(5y)7.11%
Profit Quality(3y)540.29%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.91%
EPS 3Y41.89%
EPS 5Y30.74%
EPS Q2Q%-594.94%
EPS Next Y0%
EPS Next 2Y17.51%
EPS Next 3Y20.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.64%
Revenue growth 3Y9.68%
Revenue growth 5Y4.2%
Sales Q2Q%-22.1%
Revenue Next Year-1.2%
Revenue Next 2Y7.64%
Revenue Next 3Y9.95%
Revenue Next 5YN/A
EBIT growth 1Y-25.41%
EBIT growth 3Y46.12%
EBIT growth 5Y36.66%
EBIT Next Year41.67%
EBIT Next 3Y17.57%
EBIT Next 5YN/A
FCF growth 1Y-119.71%
FCF growth 3YN/A
FCF growth 5Y-14.36%
OCF growth 1Y-56.2%
OCF growth 3Y42.71%
OCF growth 5Y-5.01%